- INCI Info
- What is INCI
- INCI FAQs
- On-line Application
- INCI Application - Complete Details
- INCI Nomenclature Conventions
- INCI Application - Name Assignment Timetable
- INCI Name Change Procedure
- INCI Process Flow Chart
- INCI Name Changes
- The International Cosmetic Ingredient Nomenclature Committee
- 2017 INCI Meeting Dates
- Regulatory Information
- Typographical Corrections to INCI Names
- Contact Information
- Member & Industry Resources
- On-Line INFOBASE
- Certificates for Export
- Council Committees
- Events & Webinars
- Career Center
- Industry Connections
- Ingredient Buyers' Guide
- Standardized Raw Material Information Form (RMIF)
- INCI Application
- Supplier Directory
- Science & Safety
- Legislation & Regulation
- Legislative Advocacy
- Industry Regulation
- Labeling & Packaging
- Political Action Committee
- Related Agencies & Regulations
- Global Strategies
- Public Information
- News Room
Council Appoints Halyna Breslawec New Chief Scientist
Submitted by 32652.49986 on June 10, 2011
For Immediate Release:
June 8, 2011
Contact: Kathleen Dezio, (202) 454-0302 or Maiya Dacey, (202) 454-0316
Regulatory Scientist to Direct Cosmetic Industry’s Scientific Programs and Advance Safety Mission
WASHINGTON, D.C.--The Personal Care Products Council (the Council) announced today that Halyna Breslawec, Ph.D., will become the organization’s chief scientist, replacing John Bailey, Ph.D., who officially retires on July 29 after nine years of service. In her new role, Breslawec will oversee the Council’s scientific programs, technical committees and publications and will serve as the industry’s scientific liaison for several domestic and international organizations.
“Halyna’s scientific credentials and background are impressive, and we are so pleased that she will soon be managing our scientific programs,” said Lezlee Westine, Council President & CEO. “She brings a great scientific foundation and proven leadership skills to the Council and will be a wonderful asset in her work on behalf of an industry that is committed to product safety, quality, and innovation.”
Breslawec worked at the U.S. Food and Drug Administration (FDA) for more than 14 years in numerous leadership roles directing the review and approval of medical devices at both the office and division levels. She assessed clinical trials as well as the organization and structure of operational units at the Center for Devices and Radiological Health. While working in the FDA Commissioner’s office Breslawec also developed a program to implement FDA's human subject protection regulations for the clinical and academic communities.
Breslawec currently serves as Deputy Director for the Cosmetic Ingredient Review (CIR), an independent, non-profit panel of scientific and medical experts that assesses the safety of cosmetic ingredients used in the U.S. She is responsible for planning and executing CIR activities while serving as liaison between the expert panel and the CIR professional staff.
Prior to joining CIR, Breslawec worked as a consultant where she was a recognized expert in FDA regulation. She helped medical device companies develop regulatory policies, evaluated clinical trials and prepared medical device applications for FDA submission.
She earned a Ph.D. in pharmacognosy (medicinal chemistry) and a B.S. in biochemistry from the University of Minnesota.
For more information on cosmetic and personal care products and their ingredients, visit www.CosmeticsInfo.org.
Based in Washington, D.C., the Personal Care Products Council is the leading national trade association representing the global cosmetic and personal care products industry. Founded in 1894, the Council's more than 600 member companies manufacture, distribute, and supply the vast majority of finished personal care products marketed in the U.S. As the makers of a diverse range of products millions of consumers rely on every day, from sunscreens, toothpaste and shampoo to moisturizer, lipstick and fragrance, personal care products companies are global leaders committed to product safety, quality and innovation.